Lucid Diagnostics faces Nasdaq delisting risk
- Received Nasdaq notice for stock price below $1
- 180-day compliance period until April 12, 2027
- Stock continues trading under LUCD symbol
Every EDGAR filing for Lucid Diagnostics Inc. (LUCD), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Dennis Matheis, insider filing for LUCD
Dennis Matheis, reporting
Victoria Tou-ho Lee, new insider at LUCD (amended)
Victoria Tou-ho Lee, reporting
Victoria Tou-ho Lee, new insider at LUCD
Victoria Tou-ho Lee, reporting
Lishan Aklog, insider filing for LUCD
Lishan Aklog, reporting
Ownership stake disclosure by PAVmed Inc. (amended)
PAVmed Inc., filed by